Immunologie des tumeurs et immunothérapie contre le cancer
L'Unité mixte de recherche Inserm, Gustave Roussy, Université Paris-Saclay est dirigée par le Pr Laurence Zitvogel.<En savoir plus...
Laboratoire contributeur dans les Graduate Schools
Derniers dépôts
-
-
-
C. B. Westphalen, D. Martins-Branco, G. Pentheroudakis, J. R. Beal, C. Cardone, et al.. The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development. Annals of Oncology, 2024, ⟨10.1016/j.annonc.2024.07.730⟩. ⟨hal-04724604⟩
-
Grégoire Gessain, Ahmed-Amine Anzali, Marvin Lerousseau, Kevin Mulder, Mathilde Bied, et al.. Trem2-expressing multinucleated giant macrophages are a biomarker of good prognosis in head and neck squamous cell carcinoma. Cancer Discovery, 2024, 14 (12), pp.2352-2366. ⟨10.1158/2159-8290.CD-24-0018⟩. ⟨inserm-04729854⟩
-
Anna Vyhlídalová Kotrbová, Kristína Gömöryová, Antónia Mikulová, Hana Plešingerová, Stanislava Sladeček, et al.. Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer. Journal of Extracellular Vesicles, 2024, 13 (3), ⟨10.1002/jev2.12420⟩. ⟨hal-04729134⟩